Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: Current status and future prospects

This publication has 61 references indexed in Scilit:

• Systemic Therapy of Advanced Breast Cancer
  Drugs, 1992
• Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: Preliminary results of a double-blind randomized study of the eortic breast cancer cooperative group
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• The duke afm program intensive induction chemotherapy for metastatic breast cancer
  Cancer, 1990
• High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
  Journal of Clinical Oncology, 1988
• VP-16 + adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A southwest oncology group study
  Medical and Pediatric Oncology, 1988
• A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma
  British Journal of Cancer, 1987
• A comparison of mitoxantrone and doxorubicin in breast cancer.
  Journal of Clinical Oncology, 1986
• Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1983
• Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study
  Cancer, 1976
• Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma.A southwest cancer chemotherapy study group study
  Cancer, 1974